ArticleOncogene2023

Correction: Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance.

R I Cordo Russo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.